0001415889-18-000694.txt : 20180508 0001415889-18-000694.hdr.sgml : 20180508 20180508162248 ACCESSION NUMBER: 0001415889-18-000694 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180204 FILED AS OF DATE: 20180508 DATE AS OF CHANGE: 20180508 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FORTUNOFF GREGORY CENTRAL INDEX KEY: 0001212542 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-00935 FILM NUMBER: 18814942 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medite Cancer Diagnostics, Inc. CENTRAL INDEX KEY: 0000075439 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 364296006 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 BUSINESS PHONE: 4078490290 MAIL ADDRESS: STREET 1: 414 NORTH ORLEANS STREET STREET 2: SUITE 502 CITY: CHICAGO STATE: IL ZIP: 60610 FORMER COMPANY: FORMER CONFORMED NAME: CytoCore Inc DATE OF NAME CHANGE: 20060815 FORMER COMPANY: FORMER CONFORMED NAME: MOLECULAR DIAGNOSTICS INC DATE OF NAME CHANGE: 20011009 FORMER COMPANY: FORMER CONFORMED NAME: AMPERSAND MEDICAL CORP DATE OF NAME CHANGE: 19990527 4 1 form4-05082018_010535.xml X0306 4 2018-02-04 0000075439 Medite Cancer Diagnostics, Inc. MDIT 0001212542 FORTUNOFF GREGORY C/O MEDITE CANCER DIAGNOSTICS, INC. 4203 SW 34TH ST. ORLANDO FL 32811 true false false false Common Stock 2018-04-04 4 P 0 1333334 0.75 A 1533334 D Secured Convertible Note .075 2018-02-04 4 P 0 100000 .075 A 2018-08-04 2020-02-04 Common Stock 1333334 100000 D /s/ Greg Fortunoff 2018-05-08